The assessment of using statin drugs in type 2 diabetic patients with chronic kidney disease to reduce concurrent cardiovascular disease

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEN, Chiu-Ju (Chi-Mei Hospital, Department of Pharmacy, Tainan City, China Taiwan)
  • Co-author(s): Chiu-Ju Chen: Department of Pharmacy, Chi-Mei Hospital, Tainan City, Taiwan, Province of China
    Hui-Chen Su: Department of Pharmacy, Chi-Mei Hospital, Tainan City, Taiwan, Province of China
  • Abstract:

    Background

    The patients with type 2 diabetes and chronic kidney disease (CKD) are a high risk population of cardiovascular disease (CVD). The number of kidney disease with abnormal lipid metabolism is increasing rapidly. In 2003, the National Kidney Foundation Kidney Disease Outcomes Quality Initiative recommended the patients should take statin..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login